Physician
Oncology
Dr. Kambarajapuram R. Desikan, MD
Kambarajapuram R. Desikan, MD practices Oncology. He graduated from University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences is ranked 83/35 in Research/PrimaryCare. Dr. Kambarajapuram R. Desikan is also a published doctor. He has 31 paper published. The most recent paper is: Total therapy with tandem transplants for newly diagnosed multiple myeloma. He accepts all Medicare patients.
Publications
- A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma.
- Expression of a free gamma heavy chain in serum following autologous stem Cell transplantation for IgG kappa multiple myeloma.
- Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone.
- Waldenström's macroglobulinemia.
- Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma i...
- Novel approaches in myeloma therapy.
- Collection of peripheral blood stem Cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy.
- Tumour lysis Syndrome complicating high-dose treatment in patients with multiple myeloma.
- Lymphomatoid granulomatosis following autologous stem Cell transplantation.
- Total therapy with tandem transplants for newly diagnosed multiple myeloma.
- Age is not a prognostic variable with autotransplants for multiple myeloma.
- Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping.
- Anti-myeloma activity of pamidronate in vivo.
- Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor Cells to support high dose therapy in multiple myeloma.
- Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?
- Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic Cell transplantation.
- Comparable engraftment kinetics following peripheral-blood stem-Cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in ...
- Collection of more hematopoietic progenitor Cells with large volume leukapheresis in patients with multiple myeloma.
- Advances in the treatment of multiple myeloma.
- Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation.
- Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma.
- High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplant.
- Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.
- Biology and therapy of multiple myeloma in 1996.
- Autotransplants in multiple myeloma: what have we learned?
- Hematopoietic stem Cell transplants for multiple myeloma.
- Autologous bone marrow and peripheral blood stem Cell transplantation in multiple myeloma.
- Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, proDuction, isolation and biological activity.
- Aranorosin, a novel antibiotic from Pseudoarachniotus roseus. I. Taxonomy, fermentation, isolation, chemical and biological properties.
- Mulundocandin, a new lipopeptide antibiotic. I. Taxonomy, fermentation, isolation and characterization.
Procedures Preformed
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Arkansas for Medical Sciences
-
St Elizabeth's Medical Center
-
Madras Medical College
Drug Facts
| NPI NUMBER |
|
1619973500 |
| NPPES Provider LastName |
|
DESIKAN |
| NPPES Provider FirstName |
|
KAMBARAJAPURAM |
| NPPES Provider ZIPCode |
|
722076347 |
| NPPES Provider State |
|
AR |
| Specialty Description |
|
Hematology/Oncology |
| Total Claim Count |
|
1093.0 |
| Distinct Opioid Count |
|
4.0 |
| Opioid Claim Count |
|
110.0 |
| Percent Opioid Claims |
|
10.06 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1619973500 |
| Last Name Of The Provider |
DESIKAN |
| First Name Of The Provider |
KAMBARAJAPURAM |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.